Yuki Nagata

发表

Teriparatide Therapy Reduces Serum Phosphate and Intima-Media Thickness at the Carotid Wall Artery in Patients with Osteoporosis

M. Inaba, S. Yamada, Y. Imanishi, 2015, Calcified Tissue International.

increased bone mineral density and improved metabolic bone markers in patients with hypophosphatemic rickets osteomalacia treated with the calcimimetic cinacalcet

M. Emoto, M. Inaba, Y. Imanishi, 2018 .

Association of cystatin C- and creatinine-based eGFR with osteoporotic fracture in Japanese postmenopausal women with osteoporosis: sarcopenia as risk for fracture

M. Kurajoh, M. Emoto, M. Inaba, 2019, Journal of Bone and Mineral Metabolism.

Decrease of brachial-ankle pulse wave velocity in female subclinical hypothyroid patients during normalization of thyroid function: a double-blind, placebo-controlled study.

M. Inaba, Y. Kumeda, S. Yamada, 2009, European journal of endocrinology.

Nutritional disorder evaluated by geriatric nutritional risk index predicts death after hospitalization for infection in patients undergoing maintenance hemodialysis.

M. Emoto, T. Shoji, H. Yoshida, 2022, Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation.

Increased undercarboxylated osteocalcin/intact osteocalcin ratio in patients undergoing hemodialysis

H. Koyama, Hirokazu Okazaki, S. Okuno, 2015, Osteoporosis International.

Destructive thyroiditis presenting as thyrotoxicosis followed by hypothyroidism during lenvatinib therapy for hepatocellular carcinoma

A. Tamori, A. Hagihara, N. Kawada, 2020, Clinical Journal of Gastroenterology.

Parathyroid Hormone Regulates Circulating Levels of Sclerostin and FGF23 in a Primary Hyperparathyroidism Model

A. Arnold, M. Kurajoh, M. Emoto, 2022, Journal of the Endocrine Society.

Etelcalcetide decreases the PTH–calcium setpoint without changing maximum and minimum PTH secretion in mice with primary hyperparathyroidism

M. Emoto, M. Inaba, Y. Imanishi, 2020, Journal of Bone and Mineral Metabolism.

The administration of an active vitamin D(3) analogue reduced the serum concentrations of 1-84 and truncated parathyroid hormone in pseudohypoparathyroidism type Ib patients.

M. Kurajoh, M. Inaba, Y. Nishizawa, 2010, Endocrine journal.

Parathyroid Diseases and Animal Models

M. Inaba, Y. Imanishi, Y. Nagata, 2012, Front. Endocrin..

Impaired residual renal function predicts denosumab-induced serum calcium decrement as well as increment of bone mineral density in non-severe renal insufficiency

M. Emoto, M. Inaba, S. Yamada, 2018, Osteoporosis International.

Low Free Triiodothyronine Level as a Predictor of Cardiovascular Events and All-Cause Mortality in Patients Undergoing Hemodialysis: The DREAM Cohort

M. Emoto, T. Shoji, T. Morioka, 2020, Journal of atherosclerosis and thrombosis.

Association of plasma xanthine oxidoreductase activity with vascular endothelial function independent of serum uric acid level: MedCity21 health examination registry

S. Fukumoto, M. Emoto, Y. Imanishi, 2023, International journal of cardiology. Heart & vasculature.

Effects of burosumab on osteocalcin and bone mineral density in patient with 15-year history of nonremission tumor-induced osteomalacia initially treated with conventional therapy: Case report

M. Kurajoh, M. Emoto, S. Yamada, 2020, Bone reports.

The Levels of Somatostatin Receptors in Causative Tumors of Oncogenic Osteomalacia Are Insufficient for Their Agonist to Normalize Serum Phosphate Levels

K. Wakasa, T. Ueda, J. Hashimoto, 2010, Calcified Tissue International.